HBK Investments’s Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 MACC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-30,000
Closed -$17K 1005
2021
Q3
$17K Sell
30,000
-14,800
-33% -$10.3K ﹤0.01% 723
2021
Q2
$36K Buy
+44,800
New +$29.4K ﹤0.01% 796

Other funds holding MACC.WS

HBK Investments's MACC.WS Position: Q3 2022 in Review

HBK Investments sold out of Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (MACC.WS) in Q3 2022, closing a stake of 30,000 shares — an estimated $2K sold.

HBK Investments first reported a position in MACC.WS in Q4 2021 and held it in 3 quarters. The position peaked at $15K in Q4 2021. 51 funds tracked by Wall St. Rank hold MACC.WS as of Q3 2022.

  • HBK Investments reported no remaining Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • HBK Investments sold 30,000 Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q3 2022, an estimated $2K.
  • HBK Investments first reported a position in Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q4 2021 and held it in 3 quarters.
  • HBK Investments's Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $15K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q3 2022.

Based on HBK Investments's 13F filing for Q3 2022, filed 14 Nov 2022.